Aspargo Labs, INC

S-1

New Public Companies (S-1)

AAGO
Aspargo Labs, INC
S-1/A: Aspargo Labs Files Amendment No. 1 to Form S-1 for NYSE Listing
Aspargo Labs, a specialty pharmaceutical and med-tech company, has filed an amendment to its Form S-1 registration statement for a direct listing on the NYSE, aiming to improve patient outcomes through innovative drug delivery systems.
Capital raise
Worse than expected
AAGO
Aspargo Labs, INC
S-1: Aspargo Labs Files for Direct Listing on NYSE, Eyes FDA Approval for Erectile Dysfunction Drug
Aspargo Labs, a specialty pharmaceutical and med-tech company, has filed an S-1 registration statement for a direct listing of its common stock on the NYSE, aiming to raise capital for commercializing its Sildenafil Oral Suspension and developing innovative drug delivery devices.
Capital raise